Literature DB >> 28388349

Ophthalmic involvement in nasopharyngeal carcinoma.

Wendy Meihua Wong1, Stephanie Ming Young1, Shantha Amrith1.   

Abstract

This article desribes the ophthalmic involvement in patients with nasopharyngeal carcinoma (NPC) pre- and post-treatment. We retrospectively reviewed data for 354 consecutive patients diagnosed with or treated for NPC at a single tertiary centre between April 2007 and July 2015. We identified 27 (7.6%) patients with ophthalmic involvement due to NPC or its treatment. Symptomatic orbital invasion by tumor occurred in 13 of 27 patients (48.1%). The mean age of diagnosis in these patients was 54 years, and 8 (61.5%) had no prior diagnosis of NPC. Ocular signs, but no orbital invasion, was present in 8 patients (29.6%). Incidental orbital involvement was detected on imaging in 2 patients (7.4%). Radiotherapy-related ocular complications affected 4 patients (14.8%). Ophthalmic symptoms from orbital invasion can be the initial presentation of NPC. This disease tends to affect a younger group of patients and early recognition is important to minimize morbidity and mortality.

Entities:  

Keywords:  Cancer epidemiology; cranial nerve palsy; nasopharyngeal carcinoma; orbit; radiotherapy

Mesh:

Year:  2017        PMID: 28388349     DOI: 10.1080/01676830.2017.1279658

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  3 in total

1.  A case of neck swelling with an unusual presentation.

Authors:  Swasti Jain; Manju Kaushal; Minakshi Bhardwaj
Journal:  Cytojournal       Date:  2022-01-13       Impact factor: 2.091

2.  Etiology and Clinical Features of Diplopia in South China: Analysis of 303 Cases.

Authors:  Zhonghao Wang; Binbin Zhu; Licheng Fu; Jianhua Yan
Journal:  Front Neurol       Date:  2022-02-16       Impact factor: 4.003

3.  Nasopharyngeal carcinoma (NPC) in the ophthalmic practice: A serious neoplasm presenting initially to ophthalmologists.

Authors:  Saleh H Alrashed; Hind M Alkatan; Motazz Alarfaj; Muhannad A Alnahdi; Nawaf Z Almeshari; Faris J Almutairi; Azza M Y Maktabi
Journal:  Saudi J Ophthalmol       Date:  2022-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.